Varian to make healthcare division a stand-alone business
This article was originally published in Clinica
Varian Associates is to split its three divisions, allowing each to function as separately-quoted public companies. The oncology and imaging business of the US company will be floated, along with its instrumentation and semiconductors businesses, in order to derive a quantifiable increase in shareholder value from the group. The plan also protects the other two divisions from the drag of the poorly performing semiconductor business, which faces a worldwide overcapacity and pricing slump.